Biotech & Longevity · Friday, 28 August 2026

01 Briefing what happened

A patch of muscle under the skin, attached to nothing, did much of what exercise does

Biotech & Longevity 1 min 41 sources

Mice given a self-contracting graft of their own muscle cells gained lean mass, bone density, grip and stamina - and the graft moves nothing. Plus 37 more stories from the beat's day.

bones the graft pulls on

it sits under the skin and moves nothing [1][2]

15 weeks

until bone density rose

lean mass had already risen at eight weeks [1]

1.5 years

age of the older mice

roughly elderly for a lab mouse [1]

16 weeks

the obese-mouse arm

less fat, lower blood sugar, a smaller cholesterol rise [1]

The lead story — what happened

Researchers grew muscle cells from a mouse's own thigh and injected them under the skin of its back. [1]
The cells organised into real muscle tissue, grew their own blood supply, and contracted continuously for months. [1][2]
The graft is attached to no bone and no tendon. It moves nothing and does no work. [1][2]
Older mice with a graft carried more lean mass after eight weeks and had denser bone after fifteen. [1]
They also ran farther, gripped harder, and explored more of a maze than mice without one. [1]
Mice fattened on a high-fat diet had less body fat, lower blood sugar and a smaller cholesterol rise. [1]
Signs of body-wide inflammation fell too: fewer white blood cells, lower fats in the blood, less liver damage. [1]
The benefits landed in bone, fat, liver and brain. The graft touches none of them. [1]
So the good arrives as chemistry. A working muscle releases signal proteins into the blood, and those travel. [1][2]
The team also gave grafts the genes for two hormones, so the tissue made those drugs continuously. [2]
It is mice, and the authors call it a proof of concept. [1]
James White of Duke University says a person would probably need several grafts, meaning several operations. [1]

What is pushing on this

Need for an exercise substitute High↑

muscle wasting has no good answer except exercise [1]

Evidence muscle is a chemical organ Building↑

the gains landed in bone, liver, fat and brain, none of them touched [1]

Distance from a person High→

mice only, and the authors call it a proof of concept [1]

Cost of getting the graft in Building↑

Duke's James White expects several grafts, so several operations [1]

Who is involved

Shyh-Chang Ng — co-author; says the people who most need exercise are often the ones who cannot do it Institute for Stem Cells and Regenerative Medicine, Beijing — where the grafts were built and tested James White, Duke University — not involved; warns frail patients would face repeat surgery Nature Aging — published the study on 26 August

How it unfolded

Day 0 muscle stem cells from the mouse's own thigh go under the skin of its back [1]
8 weeks older mice with grafts carry more lean mass than controls [1]
15 weeks their bone density is higher too [1]
16 weeks obese mice with grafts have less fat and lower blood sugar [1]
Months in the grafts are still alive and still contracting when tissue is collected [1]

Where this points

Watch whether the graft works in an animal larger than a mouse, and how many a person would need - that number decides everything. [1]

The rest of the day

37 more stories on this beat.

Each with its own sources. None of these is a link to the story above.

02
Updated Covid shots cleared for autumn

The FDA approved updated Covid vaccines on Thursday, for everyone 65 and over and for younger people with a qualifying condition. [3]

Why it matters — Pfizer said it would ship immediately, but the eligibility rules and a legal dispute could still block some people.
03
Two measles deaths in Pennsylvania

Two unvaccinated Lancaster County residents died of measles, the first US deaths this year. The CDC counted 2,777 cases in 2026. [4][5][6]

Why it matters — That is the worst US year since 1991, and five deaths in two years, more than the whole of the previous three decades. [4]
04
First pill approved for dermatomyositis

The FDA approved Lisraya, a once-daily tablet, for dermatomyositis in adults - a rare disease in which the immune system attacks muscle and skin. [7]

Why it matters — It is the first oral option, from a 241-patient trial, and carries a boxed warning for infections, cancers, clots and death. [7]
05
Samoa letter contradicts Kennedy's testimony

The AP and the Guardian obtained a 2019 letter in which Robert F. Kennedy Jr. asked Samoa's prime minister to let him study its measles vaccines. [8]

Why it matters — He told senators weighing his confirmation the trip had nothing to do with vaccines. The letter uses the word eight times. [8]
06
Inhaled RNA reads past a broken stop

Toronto researchers inhaled engineered transfer RNAs into mice and patient-derived tissue. Cells read past a faulty stop signal and made working CFTR protein. [9]

Why it matters — Stop-signal mutations of this kind cause about 11% of human genetic disorders. This was cells, mice and lab-grown tissue, not people. [9]
07
Tezspire clears a third disease

AstraZeneca and Amgen said Tezspire met every goal of a late-stage trial in a swallowing disorder called eosinophilic esophagitis. No figures were released. [10]

Why it matters — More than 470,000 Americans have the condition, and the drug already sells over $1bn a year. [10]
08
Reprogrammed cells hit rheumatoid arthritis

Six people with severe rheumatoid arthritis got one dose of their own immune cells, re-engineered to strip out the B cells making the harmful antibodies. [11]

Why it matters — All six had only a mild inflammatory reaction, none had lasting harm, and the trial moves to its second stage. [11]
09
Shingles shot linked to fewer heart events

Among US adults over 60, the newer shingles vaccine was linked to a 9% lower burden of heart disease, heart failure and stroke over seven years. [12]

Why it matters — The authors used a swift national switch between two shingles vaccines as a natural comparison, then called for real trials. [12]
10
Rectal cancer trial spares the rectum

In the STAR-TREC trial, four in five patients given chemotherapy and radiotherapy avoided major surgery for up to a year, against three in five on radiotherapy alone. [13]

Why it matters — Standard treatment often means losing the rectum and living with a permanent stoma bag. Thirty-month results are still being analysed. [13]
11
Governor and health secretary clash

Pennsylvania governor Josh Shapiro said he was very blunt with Kennedy about the administration's rhetoric on vaccines. Kennedy accused him of gaslighting. [14]

Why it matters — International officials meet in November to decide whether the US has lost the measles-free status it has held since 2000. [4]
12
An algorithm writes the vaccine

In Merck and Moderna's personalised cancer vaccine, software reads thousands of tumour mutations and picks 34 targets to encode. The rules are not public. [15]

Why it matters — Moderna is raising $2bn a week after the trial succeeded, while some investors doubt the personalising step is needed at all. [15]
13
Stomach cancer gets a two-drug approval

The FDA approved zanidatamab with tislelizumab as a first treatment for HER2-positive stomach and oesophageal cancer, plus two tests that find the right patients. [16]

Why it matters — It rests on HERIZON-GEA-01, a three-arm global trial measuring both time without growth and overall survival. [16]
14
Drugs aimed at an inherited heart risk

About one in five people carry high levels of Lp(a), a blood particle set largely by genetics that raises heart risk. Novartis leads several late-stage trials. [39]

Why it matters — Diet and current drugs barely shift it, so there is nothing to offer the people who have it. [39]
15
A heart-drug class faces its test

Cardiologists meet in Munich on Friday to hear why AstraZeneca and Ionis's eplontersen failed to cut cardiovascular deaths in a disease caused by a misfolded protein. [40]

Why it matters — Alnylam sells two drugs for the same disease, so a rival's failure clouds how well the whole approach works. [40]
16
More Medicaid price deals due Monday

Bloomberg reported the White House will announce another round of drug-pricing deals with mid-sized biotechs. Reuters said it could not verify the report. [17]

Why it matters — Seventeen companies have already signed, agreeing to charge state Medicaid programmes what they charge abroad. [17]
17
McKesson buys a trials business

The drug distributor McKesson agreed to buy Precision Medicine Group, which runs clinical trials and product launches, for about $2.25bn. [18]

Why it matters — It joins McKesson's cancer arm, moving the company that ships the drugs closer to the trials that create them. [18]
18
Boston's seed money fell 39%

MassBio reported seed funding for Massachusetts startups fell 39% in the first half of 2026, to $4.65m. The state lost 3,605 biopharma jobs. [19]

Why it matters — Later-stage money is plentiful. The shortfall sits at the front end, where new companies are made. [20]
19
China licensing reshapes the pipeline

Licensing deals for drugs discovered in China brought $79bn last year, against about $1bn in 2019. China now runs more early-stage trials than anywhere else. [20]

Why it matters — A proposed US bill to curb those ties could push the deals through Europe instead, executives told STAT. [15]
20
Metsera's backers start again

Sentivera emerged with $83m and a deal worth up to $1.46bn, paying Haisco Pharmaceutical $40m upfront for an inflammation drug cleared to start trials in China. [21]

Why it matters — The same investors sold Metsera to Pfizer after a bidding war, then incorporated Sentivera twelve days later. [21]
21
Duchenne decision pushed back

The FDA delayed its verdict on Capricor's Duchenne cell therapy by three months, after the company filed follow-up data narrowing it to upper-limb function. [22]

Why it matters — Late data counts as a major amendment, which restarts part of the review clock. [22]
22
Cell therapy plant cuts 100 jobs

Cellares, which automates the making of cell therapies, is laying off 100 people by 20 October, mostly software engineers and quality staff. [23]

Why it matters — It is the second cell-therapy manufacturer to cut staff this year, while the therapies themselves keep winning approvals. [23]
23
An HIV drug tidies aged blood

Aged mice make too many of one kind of white blood cell. Blocking a single signal with maraviroc, an approved HIV drug, reversed that. [24]

Why it matters — That cell ratio predicts death in older people, so a licensed drug now has an ageing question attached to it. [24]
24
A shortcut around eating less

Yale researchers found moderate calorie cutting lowers an immune protein called C3. Blocking C3 directly reduced age-related inflammation in mice, with no dieting. [25]

Why it matters — Severe restriction makes mice prone to infection and stunts growth, which is why a substitute is being hunted. [25]
25
Support cells rebuilt into neurons

A nanoparticle cage carrying antibodies turned astrocytes, the brain's support cells, into new neurons in mice with an Alzheimer's-like condition. The mice thought better. [26]

Why it matters — The team hopes to test it in people within a few years. Nothing here has been tried in a human brain. [26]
26
A smaller gene editor, tuned by model

Researchers used model guidance on thin data to evolve a compact gene editor, FanzMAX, hitting 97% editing at its best site and beating two rivals 2.6-fold. [27]

Why it matters — Small editors fit into delivery vehicles the big ones do not. This one edited a cholesterol gene in humanised mice. [27]
27
RNA delivered into the cornea

A new carrier particle delivered RNA, including CRISPR machinery, into the cornea's inner cell layer in mice, a human donor eye and a monkey. [28]

Why it matters — That layer does not regenerate, and its failure causes several blinding conditions. The particle can also be given more than once. [28]
28
The DNA alarm that keeps order

Mice lacking cGAS, a sensor that spots stray DNA, aged faster and died sooner. Old jumping genes woke up and set off inflammation. [29]

Why it matters — Groups have been trying to block cGAS to slow ageing. This says the same protein also holds the genome quiet. [29]
29
Bat genomes read for long life

Researchers assembled near-complete genomes for eight Myotis bat species, whose lifespans differ widely, and found selection tied to longevity, cancer resistance and virus tolerance. [30]

Why it matters — These bats handle DNA viruses and RNA viruses by different genetic routes from every other mammal studied. [30]
30
Britain's sugar rationing, 70 years on

Children whose first 1,000 days fell under postwar British sugar rationing had lower rates of several cancers, slower biological ageing, and still ate less sugar at 50. [31]

Why it matters — Rationing ended in September 1953, splitting children born months apart into two groups. That is as close to an experiment as this gets. [31]
31
A spinal-fluid marker for Alzheimer's

Across 2,069 spinal fluid samples, a tau fragment called p-tau205 rose with disease stage and predicted later build-up of amyloid and tau on brain scans. [32]

Why it matters — A marker that moves ahead of the damage gives trials something to measure before symptoms arrive. [32]
32
Greenland shark eyes barely age

Greenland sharks live up to 400 years. UC Irvine researchers found healthy retinal tissue and working blue-light proteins in animals long assumed to be blind. [33]

Why it matters — DNA repair may be what keeps the tissue going. Human eyes have no equivalent. [33]
33
Synapses lost before the inflammation

In mice, a protein called ERBB4 appearing in excitatory neurons drove Alzheimer's damage, with support cells eating those connections while sparing the calming ones. [34]

Why it matters — It suggests the inflammation blamed for early synapse loss may not be needed to cause it. [34]
34
Zika vaccine protected without antibodies

A Zika vaccine redesigned to avoid a dangerous antibody effect still protected mice - through killer T cells rather than antibodies. That protection was short-lived. [35]

Why it matters — Antibodies were assumed to be the whole defence for this kind of vaccine. Here they were not. [35]
35
Why older embryos fail to implant

Embryos from older mice were mechanically too stiff: their outer layer squeezed too hard, so the embryo could not spread and settle into the womb. [36]

Why it matters — The same age-linked stiffness showed up in human embryos and IVF records, and can be seen without touching the embryo. [36]
36
The brain's insulation and memory loss

In human brains, faster cognitive decline went with thinner axons, thicker insulation and more myelin-making cells switching off a protein called NRF2. [37]

Why it matters — Aged mice missing NRF2 in those cells showed the same picture, naming a target for keeping thinking sharp. [37]
37
More languages, younger-looking brains

People fluent in four languages had brains that looked about 13 years younger than single-language speakers, on estimates presented at a European neuroscience meeting. [41]

Why it matters — It is a conference presentation and a correlation. People who learn languages differ in many other ways. [41]
38
Skin kept alive for a month

Outer Bio says it keeps donated human skin alive and behaving like skin for about a month, against roughly a week normally, then screens compounds on it. [38]

Why it matters — Its founder Michael Polansky does not want to run it as a drug company. The work is so far a preprint. [38]

02 Lesson why it matters

The thing it is named for is not the thing it does

Muscle was named for moving you. Its quieter job is chemical, and that is the one exercise is really for.

The twist

Muscle was named for the job you can see. Its other job, talking chemically to the rest of the body, is the one exercise is really for.

How it works

A muscle contracts
While contracting it releases signal proteins into the blood
Those signals reach bone, fat, liver and brain
Put a contracting graft under the skin and the signals still go out
So the benefit arrives with no work done at all

Where you've seen this

Beekeeping

kept for honey; the pollination it does on the side is worth far more

Street lighting

installed so people can see; mostly it changes who is willing to be out

A corner shop

sells milk, and also tells the street that somebody is watching it

Commuting to an office

paid for as hours at a desk; much of the value was the corridor conversation

The catch

The second job is not always separable from the first. These mice still needed surgery, and a graft under the skin is not a walk outdoors.

And the whole of it

Everyone here reads the visible half - the researchers, the doctor saying walk more, the reader counting steps. The traffic underneath is what moves, and no seat sees it.

03 Lab your turn

Find the route

Cut each possible path out of a muscle graft until only the chemical one is left.

04 Truth what's really going on

What is really going on

Ageing research is converging on one commercial target - people who cannot exercise, cannot diet and cannot wait - and three separate papers this week each offered a way to skip the effort. [1][24][25]

Why it works on us — A result in mice reads as a result about us, because the sentence stays the same either way: they ran farther, gripped harder, and thought better. [1]

Who gains

Moderna — It raised $2bn in convertible debt one week after its cancer vaccine trial succeeded, on terms that result made possible. [15]
AstraZeneca and Amgen — A third approved use for Tezspire adds a 470,000-patient US market to a drug already selling over $1bn a year. [10]
Haisco Pharmaceutical — It handed one early drug to Sentivera and took $36m of stock, 17.5% of the company, and the China rights. [21]
McKesson — Buying Precision Medicine Group puts the firm that distributes drugs inside the trials that create them, for about $2.25bn. [18]
Biotechs with late-stage data — Investors have moved to ready-made prospects, so a company with results raises easily while the seed stage shrinks. [20]

Who pays

The earliest US startups — Massachusetts seed funding fell 39% to $4.65m in six months, and the riskiest science is what stops being funded. [19][20]
The 100 people leaving Cellares — Mostly software engineers and quality staff, out by 20 October, as cell-therapy manufacturing consolidates around fewer plants. [23]
Families waiting on Capricor's Duchenne therapy — The FDA decision slipped three months after the company filed follow-up data narrowing the treatment to upper-limb function. [22]
Unvaccinated households in Lancaster County — Two people died there, inside the worst US measles year since 1991, of a disease a 97%-effective vaccine prevents. [4][5]
Frail and bedbound patients — They are the myograft's whole reason for existing, and the least able to take the repeat surgery it would need. [1]

What nobody knows yet

Open questions from across today’s stories — ours included.

01

How many grafts a person would need, and whether one works outside a mouse.

Nothing larger than a mouse has been tried. James White of Duke expects several grafts, and so several operations. [1]
02

Whether the myograft's benefits hold past a few months.

The grafts were collected for study rather than followed to the end of the animals' lives, so nobody has a long curve. [1]
03

What is inside the algorithm that chooses Merck and Moderna's cancer vaccine targets.

The companies call it proprietary. A cancer vaccine researcher at the University of North Carolina said plainly that he has no idea. [15]
04

How large Tezspire's benefit in eosinophilic esophagitis actually is.

AstraZeneca and Amgen said the trial met every goal and released no figures, promising them at a later medical meeting. [10]
05

Whether the shingles vaccine really protects the heart.

The 9% figure comes from comparing people vaccinated either side of a national switch, not from a trial. The authors say trials are needed. [12]
06

Which drugmakers signed the pricing deals due to be announced on Monday.

Bloomberg reported the round and named nobody. Reuters said it could not verify the report at all. [17]
07

Whether the United States keeps its measles-free status.

The review happens in November. Until then the only settled numbers are 2,777 cases and two deaths. [4][5]

05 Hope carry this

The people who cannot exercise have spent a long time being told to exercise. Somebody finally went looking for what exercise actually does, so it could be handed to them another way.